BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9107382)

  • 1. The in vivo expression patterns of individual type I interferon genes in murine cytomegalovirus infections.
    Yeow WS; Lai CM; Beilharz MW
    Antiviral Res; 1997 Mar; 34(1):17-26. PubMed ID: 9107382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro expression patterns of individual type I interferon genes in Newcastle disease virus infected murine splenocytes and fibroblasts.
    Yeow WS; Beilharz MW; Lai CM
    Int J Biochem Cell Biol; 1997 Mar; 29(3):513-20. PubMed ID: 9202430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.
    Bartlett EJ; Cull VS; Brekalo NL; Lenzo JC; James CM
    Immunol Cell Biol; 2002 Oct; 80(5):425-35. PubMed ID: 12225378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression patterns of type I interferon subtypes in mouse embryo fibroblasts: influence of genotype and viral inducer.
    Lai MC; Yeow WS; Boyer SJ; Beilharz MW
    Antiviral Res; 1994 Aug; 24(4):327-40. PubMed ID: 7527624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.
    Quinnan GV; Manischewitz JF
    J Virol; 1987 Jun; 61(6):1875-81. PubMed ID: 3033318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-κB mediated transcription.
    Chan B; Gonçalves Magalhães V; Lemmermann NAW; Juranić Lisnić V; Stempel M; Bussey KA; Reimer E; Podlech J; Lienenklaus S; Reddehase MJ; Jonjić S; Brinkmann MM
    PLoS Pathog; 2017 May; 13(5):e1006382. PubMed ID: 28542326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse genotype affects inducible expression of cytokine genes.
    Raj NB; Cheung SC; Rosztoczy I; Pitha PM
    J Immunol; 1992 Mar; 148(6):1934-40. PubMed ID: 1371793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon structural genes do not participate in quantitative regulation of interferon production by If loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster.
    De Maeyer-Guignard J; Dandoy F; Bailey DW; De Maeyer E
    J Virol; 1986 Jun; 58(3):743-7. PubMed ID: 2422400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection.
    Lathbury LJ; Allan JE; Shellam GR; Scalzo AA
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2605-13. PubMed ID: 8887497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection.
    Tang-Feldman YJ; Wojtowicz A; Lochhead GR; Hale MA; Li Y; Pomeroy C
    J Virol Methods; 2006 Feb; 131(2):122-9. PubMed ID: 16140399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication.
    Yeow WS; Lawson CM; Beilharz MW
    J Immunol; 1998 Mar; 160(6):2932-9. PubMed ID: 9510197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo.
    Bosio E; Beilharz MW; Watson MW; Lawson CM
    J Interferon Cytokine Res; 1999 Aug; 19(8):869-76. PubMed ID: 10476931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice.
    Cull VS; Broomfield S; Bartlett EJ; Brekalo NL; James CM
    Gene Ther; 2002 Oct; 9(20):1369-78. PubMed ID: 12365002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection.
    Allan JE; Shellam GR
    J Gen Virol; 1985 May; 66 ( Pt 5)():1105-12. PubMed ID: 2582082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
    Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
    Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
    Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
    J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.